Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1954 1
1955 1
1956 2
1957 3
1958 3
1959 5
1960 5
1961 5
1962 6
1963 9
1964 12
1965 5
1966 7
1967 7
1968 8
1969 9
1970 13
1971 10
1972 8
1973 2
1974 11
1975 12
1976 11
1977 19
1978 22
1979 22
1980 31
1981 32
1982 30
1983 25
1984 43
1985 57
1986 62
1987 66
1988 64
1989 62
1990 60
1991 65
1992 75
1993 103
1994 78
1995 88
1996 114
1997 116
1998 101
1999 94
2000 109
2001 117
2002 135
2003 117
2004 142
2005 163
2006 201
2007 198
2008 202
2009 177
2010 218
2011 225
2012 235
2013 230
2014 289
2015 277
2016 299
2017 340
2018 333
2019 349
2020 391
2021 339
2022 325
2023 291
2024 194

Text availability

Article attribute

Article type

Publication date

Search Results

6,769 results

Results by year

Filters applied: . Clear all
Page 1
Identification of biomarkers for assessing treatment efficacy of chemotherapy plus nivolumab as the first line in patients with unresectable advanced or recurrent gastric cancer: a multicenter study.
Nakazawa N, Sohda M, Hosoi N, Watanabe T, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: yamashita t. Oncology. 2024 Sep 12:1-17. doi: 10.1159/000540841. Online ahead of print. Oncology. 2024. PMID: 39265540
Signal flow in the NMDA receptor-dependent phosphoproteome regulates postsynaptic plasticity for aversive learning.
Funahashi Y, Ahammad RU, Zhang X, Hossen E, Kawatani M, Nakamuta S, Yoshimi A, Wu M, Wang H, Wu M, Li X, Faruk MO, Shohag MH, Lin YH, Tsuboi D, Nishioka T, Kuroda K, Amano M, Noda Y, Yamada K, Sakimura K, Nagai T, Yamashita T, Uchino S, Kaibuchi K. Funahashi Y, et al. Among authors: yamashita t. Sci Signal. 2024 Sep 10;17(853):eado9852. doi: 10.1126/scisignal.ado9852. Epub 2024 Sep 10. Sci Signal. 2024. PMID: 39255336
A Pooled Analysis of Trastuzumab Deruxtecan in Patients With HER2-Positive Metastatic Breast Cancer With Brain Metastases.
André F, Cortés J, Curigliano G, Modi S, Li W, Park YH, Chung WP, Kim SB, Yamashita T, Pedrini JL, Im SA, Tseng LM, Harbeck N, Krop I, Nakatani S, Tecson K, Ashfaque S, Egorov A, Hurvitz SA. André F, et al. Among authors: yamashita t. Ann Oncol. 2024 Sep 4:S0923-7534(24)03928-0. doi: 10.1016/j.annonc.2024.08.2347. Online ahead of print. Ann Oncol. 2024. PMID: 39241960
Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study.
Nakazawa N, Sohda M, Hosoi N, Watanabe T, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: yamashita t. Ann Surg Oncol. 2024 Sep 3. doi: 10.1245/s10434-024-16161-4. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39225857
High-Throughput Screening of Antiviral Compounds Using a Recombinant Hepatitis B Virus and Identification of a Possible Infection Inhibitor, Skimmianine.
Yoshita M, Funaki M, Shimakami T, Kakuya M, Murai K, Sugimoto S, Kawase S, Matsumori K, Kawane T, Nishikawa T, Nakamura A, Suzuki R, Ishida A, Kawasaki N, Sato Y, Li YY, Sumiyadorj A, Nio K, Takatori H, Kawaguchi K, Kuroki K, Kato T, Honda M, Yamashita T. Yoshita M, et al. Among authors: yamashita t. Viruses. 2024 Aug 22;16(8):1346. doi: 10.3390/v16081346. Viruses. 2024. PMID: 39205320 Free PMC article.
Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab.
Hagiwara K, Matsuki T, Okada T, Fushimi C, Kondo T, Takahashi H, Okamoto I, Tokashiki K, Hanyu K, Kishida T, Ito T, Yamashita G, Tsukahara K, Masubuchi T, Tada Y, Momiyama K, Yaguchi R, Oridate N, Omura GO, Yamashita T. Hagiwara K, et al. Among authors: yamashita t. Anticancer Res. 2024 Sep;44(9):4057-4072. doi: 10.21873/anticanres.17235. Anticancer Res. 2024. PMID: 39197913
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials.
Borrego MR, Lu YS, Reyes-Cosmelli F, Park YH, Yamashita T, Chiu J, Airoldi M, Turner N, Fein L, Ghaznawi F, Singh J, Pantoja K, Schnell C, Akdere M, Chia S. Borrego MR, et al. Among authors: yamashita t. Breast Cancer Res Treat. 2024 Aug 23. doi: 10.1007/s10549-024-07405-8. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39177931
Long-Term Outcomes of Carbon Dioxide Insufflation in Thoracoscopic Esophagectomy After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.
Otsuka K, Goto S, Ariyoshi T, Yamashita T, Saito A, Kohmoto M, Kato R, Motegi K, Yajima N, Murakami M. Otsuka K, et al. Among authors: yamashita t. Cureus. 2024 Jul 21;16(7):e65053. doi: 10.7759/cureus.65053. eCollection 2024 Jul. Cureus. 2024. PMID: 39171044 Free PMC article.
6,769 results